Take PNRA Profits
Lock in 32% Gainer
Dear Bottarelli Research Member,
Good morning. We have more sovereign debt news in play today, as Fitch lowered Portugal’s debt raging from AA to AA-. But of course, even as the number of countries being added to the debt doghouse continues to rise, the markets still don’t seem to care. Therefore, we’re still walking a fine line between an ignorantly bullish market and a very troubling global debt situation.
As traders, all we can do is play the intra-day trends as quickly and profitably as possible. In that spirit, I’d like to ring the register on our PNRA April 80 Calls (O:PNRA 10D80.00). As you know, we entered these calls yesterday for $1.40, and they just hit a high of $1.85, good for a quick 32% gainer. Take the money and run!
PLAY: Sell your PNRA April 80 Calls (O:PNRA 10D80.00) at market, good for the day.
And as always…
Lock and load!
Sincerely,
© 2012 CSR Group, LLC. All rights reserved. Published in USA.
Information, opinion, research, and commentary contained herein is obtained from sources believed to be reliable; their reliability, however, cannot be guaranteed. The maxim of Caveat Emptor applies — let the buyer beware. Bottarelli Research does not provide individual investment advice, act as an investment advisor, or individually advocate the purchase or sale of any security or investment.
Investments recommended in this service should be made only after consulting with your investment advisor, and only after reviewing the prospectus or financial statements of the company. Bottarelli Research reserves the right to use e-mail endorsements and/or profit claims from its subscribers for marketing purposes. All names will be kept anonymous and only subscriber’s initials will be used unless express written permission has been granted to the contrary.
CSR Group, LLC expressly forbids its writers from having a financial interest in any security recommended to readers. Furthermore, all employees and agents of CSR Group, LLC and its affiliate companies must wait 24 hours before following a published recommendation.